UPN,TCGA Patient ID,WGS#,RNAseq data?,Expired?  3.31.12,Sex,Race,FAB,Age,%BM Blast,WBC,%PB Blast,Cytogenetics,Gene Fusions by RNA-Seq,Inferred genomic rearrangement (from RNA-Seq fusion),Cytogenetic Classification,RISK (Cyto),Molecular Classification,RISK (Molecular),SVs (from WGS),EFS months    3.31.12,OS months  3.31.12,Days from collection to first Relapse,de novo U133        JP 101410,In house Normal SNP   JP 1014810,In house Tumor SNP   JP 101410,Induction,Trnsplt,Dz Stat @  trnsplt
110,2803, ,Yes,*,F,W,M3,61,44,1, ,46;XX;t(15;17)(q22:q21)[15],PML(+)RARA(+) (In frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good, ,24.1,25.7,734,7490,14848,14847,7+3+ATRA,0,0
237,2806, ,Yes,*,M,W,M1,46,90,29.4,81,45;X;-Y; t(8;7;21)(q22;p15;q22[22]/46;XY[3],RUNX1(+)RUNX1T1(+) (In Frame);CDK11B(-)SLC35E2(-) (Out of Frame),t(21;8)(q22.3;q22); dup1p36.33,RUNX1-RUNX1T1,Good,RUNX1-RUNX1T1,Good, ,16.1,30.6,490,6318,14122,14118,7+3+3+PSC,MUD,CR 2
146218,2870, ,Yes,*,M,W,M1,76,73,34,55,46;XY;inv(16)(p13q22)[9]/46;XY[10],MYH11(-)CBFB(-)  (In Frame);TBC1D16(-)KIAA1618(+)  (Out of Frame),t(16;16)(p13.11;q22.1); dup17q25.3,CBFB-MYH11,Good,CBFB-MYH11,Good, ,4.5,4.5,unknown,17908,18186,18185,7+3,0,0
156704,2815, ,Yes,*,M,W,M4,49,81,57.1,48,46;XY;inv(16)(p13q22)[17]/46;XY[3],MYH11(+)CBFB(+) (In Frame),t(16;16)(p13.11;q22.1),CBFB-MYH11,Good,CBFB-MYH11,Good, ,14.2,26.3,431,7503,14143,14148,7+3+3,MUD,Rel 2
179016,2872, ,Yes, ,M,B,M3,42,88,2.1,2,46;XY;del(9)(q13:q22);t(11:21)(p13;q22);t(15;17)(q22;q210[20],PML(-)RARA(-) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good, ,43.4,43.4,N/A,18062,18190,18189,7+3+ATRA,0,0
202127,2998,48,Yes,*,F,W,M3,68,85,29,32,46;XX;t(15;17)(q22;q21)[20],PML(+)RARA(+)(2) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good,15:72104255-17:35741663(CTX);15:72104247-17:35741661(CTX);15:72104257-17:35741661(CTX),1,1,N/A,17883,17575,17574,7+3+ATRA,0,0
258135,2914, ,Yes, ,F,W,M2,22,55,51.8,70,46;XX;inv(16)(p13q22)[5]/46;idem;t(3;3)(p13;q?28)[5]/46;XX[6],MYH11(-)CBFB(-) (In Frame);FOXP1(+)PPP1R2(-) (Out of Frame),t(16;16)(p13.11;q22.1); t(3;3)(p14.1;q29),CBFB-MYH11,Good,CBFB-MYH11,Good, ,48.3,48.3,N/A,18135,16022,16023,7+3,0,0
263578,2819, ,Yes,*,F,W,M2,52,67,4.1,18,46;XX;t(8;21)(q22;q22)[17]/46;XX[3],RUNX1(-)RUNX1T1(-) (In Frame),t(21;8)(q22.3;q22),RUNX1-RUNX1T1,Good,RUNX1-RUNX1T1,Good, ,95.6,95.6,N/A,6327,14123,14138,7+3+3,0,0
275786,2875, ,Yes, ,M,NH/C,M2,43,40,4.3,39,45;X;-Y;t(8;21)(q22;q22)[19]/46;XY[1],RUNX1(-)RUNX1T1(-) (In Frame),t(21;8)(q22.3;q22),RUNX1-RUNX1T1,Good,RUNX1-RUNX1T1,Good, ,27.7,27.7,N/A,18136,18220,18219,7+3+3,0,0
291696,2823, ,Yes,*,F,W,M3,61,73,86.4,68,47;XX;t(15;17)(q22:q21)+mar[20],PML(-)RARA(-)(2) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good, ,0.2,0.2,N/A,11415,14680,14679,Hydrea; ATRA started,0,0
318433,2828, ,Yes, ,M,W,M4,55,35,22.2,8,46;XY;t(2;4)(q34;q21)inv(16)(p13q22) [20],MYH11(-)CBFB(-) (In Frame);GPR128(+)TFG(+) (In Frame);NOD2(+)Storry(-) (Out of Frame),t(16;16)(p13.11;q22.1); dup3q12.2; inv16q21-16q12.1,CBFB-MYH11,Good,CBFB-MYH11,Good, ,99.9,99.9,N/A,6331,14132,14135,7+3+3,0,0
321258,3001,14,Yes, ,F,W,M3,31,40,1.6,0,46;XX;t(15;17)(q22;q21)[11]/46;XX[9],PML(-)RARA(-)(2) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good,15:72103872-17:35752513(CTX);15:72103870-17:35752514(CTX),76.2,76.2,N/A,10572,14674,14673,7+3+ATRA,0,0
344551,2905,12,No Sample, ,M,H,M3,48,65,0.6,28,46;XY;t(15;17)(q22:q21)[11]/46;XY[8], , ,PML-RARA,Good,PML-RARA,Good,15:72113342-17:35755293(CTX);15:72113343-17:35755292(CTX),81.3,81.3,N/A,9684,14662,14661,7+3+ATRA,0,0
345701,2881,69,Yes,*,F,NH/C,M1,48,75,33.2,41,46;XX;inv(16)(p13q22)[19]/46;XX[1],MYH11(-)CBFB(-) (In Frame),t(16;16)(p13.11;q22.1),CBFB-MYH11,Good,CBFB-MYH11,Good, ,8.8,29.7,267,18153,18229,18228,7+3; IT,MUD,CR 3
447649,2840, ,Yes,*,M,W,M3,74,51,31.5, ,46;XY;t(15;17)(q22;q21)[20],PML(-)RARA(-)(2) (In Frame);ACAD10(-)MAPKAPK5(-) (Out of Frame);GAS6(+)FAM70B(-) (Out of Frame),t(15;17)(q22;q21); dup12q24.12-13; dup13q34,PML-RARA,Good,PML-RARA,Good, ,0.7,0.7,N/A,6333,14120,14127,Hydrea & Idarubicin,0,0
455499,2982,16,Yes, ,F,H,M3,29,85,1.2,1,46;XX;t(15;17)(q22;q21)[12]/46;XX[8],PML(-)RARA(-) (In Frame);CUL1(+)DPP6(-) (Out of Frame),t(15;17)(q22;q21); inv7q36.1-36.2,PML-RARA,Good,PML-RARA,Good,15:72113496-17:35750399(CTX);15:72113490-17:35750402(CTX),37.1,37.1,unknown,17885,17642,17641,7+3+ATRA,0,0
463352,2886, ,Yes, ,M,NH/C,M2,25,72,11,50,45;X;-Y;t(8;21)(q22;q22)[13]/45;idem;del(9)(q22;q32)[7],RUNX1(-)RUNX1T1(-) (In Frame),t(21;8)(q22.3;q22),RUNX1-RUNX1T1,Good,RUNX1-RUNX1T1,Good, ,29.4,29.4,N/A,18148,18237,18236,7+3+3,0,0
478908,2980,11,Yes, ,M,W,M3,50,74,0.5,10,46;XY;t(15;17)(q22;q21)[20],PML(+)RARA(+)(2) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good,15:72103063-17:35756005(CTX);7:56712048-7:57544681(INV),47.5,47.5,N/A,17886,16026,16027,7+4+ATRA,0,0
499294,2888, ,Yes, ,M,NH/C,M4,57,40,4.9,0,Outside hospital with inv(16),MYH11(+)CBFB(+) (In Frame),t(16;16)(p13.11;q22.1),CBFB-MYH11,Good,CBFB-MYH11,Good, ,33.5,33.5,N/A,18158,18241,18240,7+3,0,0
501944,2991,50,Yes, ,F,W,M3,40,90,0.4,0,46;XX;t(15;17)(q22;q21.1)[19]/47;idem;+8 [1],PML(+)RARA(+)(2) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good,15:72102828-17:35748107(CTX);15:72102815-17:35748106(CTX);15:72102829-17:35748106(CTX),88.3,88.3,N/A,7509,14145,14152,7+3+ATRA,0,0
507696,2889, ,Yes,*,F,Unk/C,M4,55,52,30.9,59,46;XY;inv(16)(p13;q22)[20],MYH11(-)CBFB(-) (In Frame),t(16;16)(p13.11;q22.1),CBFB-MYH11,Good,CBFB-MYH11,Good, ,28.4,34.3,864,18150,18243,18242,7+3+3,sib Allo,CR 2
514066,2937,80,Yes,*,F,W,M1,35,81,42.8,86,46;XX;t(8;21)(q22;q22)[20],RUNX1(+)RUNX1T1(+) (In Frame),t(21;8)(q22.3;q22),RUNX1-RUNX1T1,Good,RUNX1-RUNX1T1,Good, ,4.6,8,141,18159,15978,15979,7+3,0,0
529205,2906,49,No Sample, ,M,W,M3,59,79,0.7,15,46;XY;t(15;17)(q22;q21)[20], , ,PML-RARA,Good,PML-RARA,Good,15:72113381-17:35749505(CTX);15:72113386-17:35749588(CTX);15:72113410-17:35749505(CTX),36.9,36.9,N/A,no RNA,17573,17572,7+3+ATRA,0,0
537782,2841,81,Yes,*,F,W,M3,51,93,3.6,40,46;XX;t(15;17)(q22;q21)[20],PML(-)RARA(-)(2) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good, ,5.4,46.5,165,9856,14142,14141,7+3+ATRA,0,0
595704,2942, ,Yes, ,F,W,M4,67,69,37,61,46;XX;inv(16)(p13q22)[19]/46;XX[1],MYH11(-)CBFB(-) (In Frame),t(16;16)(p13.11;q22.1),CBFB-MYH11,Good,CBFB-MYH11,Good, ,43.5,43.5,N/A,18152,15803,15804,7+3,0,0
619751,2846,85,Yes,*,F,W,M4,57,61,13.6,17,46;XX;inv(16)(p13q22)[20],MYH11(-)CBFB(-) (In Frame),t(16;16)(p13.11;q22.1),CBFB-MYH11,Good,CBFB-MYH11,Good, ,10.8,45.8,329,9687,15061,15062,7+3,MUD,CR 2
671473,2892,86,Yes, ,F,W,M4,42,40,37.9,16,46;XX;inv(16)(p13q22)[15]/46;XX[2],MYH11(+)CBFB(+) (In Frame),t(16;16)(p13.11;q22.1),CBFB-MYH11,Good,CBFB-MYH11,Good, ,9.8,59.3,298,18350,18313,18312,7+3,MUD; MUD; MUD,Rel 1; CR2; CR2
673778,3012,13,Yes, ,M,W,M3,53,42,1,29,46;XY;t(15;17)(q22;q21)[19]/46;XY[1],PML(-)RARA(-)(2) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good,15:72112749-17:35755472(CTX);15:72112751-17:35755469(CTX),86.6,86.6,N/A,9614,14664,14663,7+3+ATRA,0,0
709968,2994,9,Yes, ,M,W,M3,25,91,8.2,63,46;XY;t(15;17)(q22;q21)[20],PML(+)RARA(+)(2) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good,15:72113514-17:35752358(CTX);15:72113524-17:35752347(CTX),24.2,83.5,735,9685,14499,14498,7+3+ATRA,MUD; Auto; MUD,CR 2; CR 2; xxxxx
750152,2950, ,Yes, ,F,W,M2,34,57,14.3,59,45;X;-X;t(8;21)(q22;q22)[20],RUNX1(+)RUNX1T1(+) (In Frame),t(21;8)(q22.3;q22),RUNX1-RUNX1T1,Good,RUNX1-RUNX1T1,Good, ,40.3,40.3,N/A,17906,15853,15854,7+3+3,0,0
757199,2897, ,Yes, ,F,NH/C,M3,50,90,3.4,0,46;XX;t(15;17)(q22;q21);t(16;19)(p13.3;p13.1)[17]/46;XX[3],PML(-)RARA(-) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good, ,30.5,30.5,N/A,18201,18323,18322,7+4+ATRA,0,0
758168,2997,15,Sample Failed,*,F,W,M3,25,93,16.3,40,46;XX;t(15;17)(q22;q21)[20], , ,PML-RARA,Good,PML-RARA,Good,15:72113429-17:35756719(CTX);15:72052994-17:35833384(CTX),31.6,49.8,961,17995,17636,17635,7+3+ATRA,MUD,CR 2
862507,2954, ,Yes, ,F,Unk,M4,55,54,114.5,24,46;XX;del(16)(q22)[16]/47;XX;del(16)(q22);+22[8]/47;XX;+22[2]/46;XX[4],MYH11(+)CBFB(+) (In Frame),t(16;16)(p13.11;q22.1),CBFB-MYH11,Good,CBFB-MYH11,Good, ,68.3,68.3,N/A,11422,15814,15815,7+3+3,0,0
863018,2999,10,Yes, ,M,W,M3,62,82,0.9,11,46;XY;t(15;17)(q22:q21)[11]/46;XY[9],PML(-)RARA(-) (In Frame),t(15;17)(q22;q21),PML-RARA,Good,PML-RARA,Good,15:72113191-17:35756597(CTX);15:72129457-17:35756833(CTX);3:46994998-3:46995128(DEL),83.3,83.3,N/A,9678,14666,14665,7+3+ATRA,0,0
905179,2858, ,Yes,*,F,W,M2,75,48,8.3,54,46;XX;t(8;21)[15]/46;idem;del(9)(q12q22)[5],CRTC2(+)CREB3L4(-) (Out of Frame); RUNX1(-)RUNX1T1(-) (In Frame),dup1q21.3; t(21;8)(q22.3;q22),RUNX1-RUNX1T1,Good,RUNX1-RUNX1T1,Good, ,18.2,19.2,553,9679,15429,15054,7+3,0,0
943309,3007,51,Yes, ,M,W,M3,35,90,1.5,7,47;XY;del(7)(q22);+8;t(15;17)(q22;q21)[18]/46;XY;del(7)(q22);t(15;17)(q22;q21)[2],PML(-)RARA(-)(2) (In Frame);PLAUR(+)EXOC3L2(-)  (Out of Frame),t(15;17)(q22;q21);  inv19q13.1-q13.32,PML-RARA,Good,PML-RARA,Good,15:72103777-17:35744690(CTX),75.8,75.8,N/A,11414,15094,15095,7+3+ATRA,0,0
944281,2957, ,Sample Failed, ,M,W,M4,31,82,132.7,53,46;XY;inv(16)(p13q22)[20], , ,CBFB-MYH11,Good,CBFB-MYH11,Good, ,20.1,20.1,unknown,18208,16165,15965,7+3+3,0,0
104,2802, ,Sample Failed,*,M,W,M4,50,88,16.9,52,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,8.7,12,263,7492,18337,18336,7+3,0,0
201,2804, ,No Sample, ,M,W,M3,30,82,5.7, ,46; XY[25], , ,Normal Karyotype,Intermediate,PML-RARA,Good, ,57.2,95.3,1740,7493,14850,14849,7+3+ATRA,Auto; sib Allo,CR 2; CR 3
203,2805, ,Yes,*,M,W,M0,77,67,92,56,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,11.6,18.5,353,6317,15154,15155,7+3+3,0,0
245,2807, ,Yes,*,F,W,M1,68,91,3.1,55,47;XX;+21[24], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,4.9,4.9,N/A,6319,15138,15139,7+3+3,0,0
269,2808, ,Yes, ,M,W,M2,23,59,32.4, ,47;XXY [17], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,10,118.1,304,6320,14116,14126,7+3,sib Allo; sib Allo,CR 1; CR 4
287,2809, ,Sample Failed,*,F,W,M2,64,60,116.5, ,46;XX[24], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,1.7,2.2,53,7499,14117,14139,7+3+ATRA,0,0
296,2811, ,Yes,*,M,W,M4,81,98,90.6,37,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,8.2,8.2,248,7497,15140,15141,7+3,0,0
103342,2978,17,Yes, ,F,W,M2,61,43,9.8,32,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,35.6,44.8,1082,17903,17563,17562,7+3,MUD,CR 1
104851,2812,53,Yes,*,F,B,M2,25,53,34.2,87,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,7.3,11.5,222,9855,15432,15137,7+3,MUD,aplastic post chemo
113971,2966,18,Yes,*,F,W,M2,57,43,3.1,35,46; XX[15], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,8.6,28.4,262,17904,16006,16007,7+3,MUD,CR 1
115225,2909, ,Yes, ,M,NH/A,nc,22,80,115.4,94,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,20.6,26.1,627,18060,18076,18075,7+3+dauno,Haplo,0
123172,2963,3,Yes,*,M,W,M1,56,90,30.5,45,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate,6:104234249-6:104234390(DEL),53.9,53.9,N/A,6323,14513,14512,7+3+3+PSC,Auto; MUD,CR 1; no count recov
141273,2869, ,Yes,*,F,NH/B,M2,64,80,2.6,46,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,15.6,27.1,473,17907,18184,18183,7+3,0,0
142074,2965,19,Yes,*,M,W,M4,60,89,67.5,56,46; XY[15], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,9.9,11.3,300,17905,16029,15843,7+3,sib Allo,CR 1
150288,2871, ,Yes,*,M,NH/B,M1,51,62,1.5,10,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,13.9,22.6,423,17909,18188,18187,7+3; dauna,sib Allo,CR 2
179223,2972,20,Yes,*,F,W,M2,82,53,1.4,25,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,1.5,1.5,N/A,18297,16018,16019,Decitabine,0,0
180168,2873, ,Yes, ,F,NH/C,M5,51,57,14.9,0,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,32.7,32.7,995,18063,18192,18191,7+3,0,0
186481,2816,55,Yes,*,F,W,M4,57,90,87.5,84,46;XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,5.1,7.5,155,6325,14124,14129,7+3+3+PSC,0,0
208027,2818,58,Yes,*,F,A,M2,62,46,75.2,53,46;XX[19]/46;XX;add(7)(p?22)[1], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,6.9,10.2,210,7491,15146,15147,7+3,0,0
224143,2988,21,Yes,*,F,W,M1,67,76,45.6,49,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,0.8,0.8,N/A,17884,17577,17576,hydrea; didn't get add'l chemo,0,0
225373,2977,22,Yes,*,F,W,M2,71,70,35.9,67,46; XX[14], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,0.8,0.8,N/A,18299,17646,17645,Revlimid,0,0
245450,2912, ,Yes,*,M,W,M4,63,62,17.9,9,47;XY;+8[15]/46;+8;-17[3],FLT3LG(-)RPS11(-) (In Frame),dup19q13.3,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,8.4,8.4,N/A,18133,15966,15967,7+3,sib Allo,CR 1
246634,2968,23,Sample Failed,*,M,W,M4,79,58,18.5,0,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,14.6,14.6,N/A,18292,15962,15963,Revlimid,0,0
254137,2986,24,Yes,*,F,W,M2,31,63,12.6,45,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,6.6,6.6,N/A,18300,17579,17578,7+3+3,sib Allo,CR 1
255108,2913,60,Yes,*,M,W,M0,61,95,61.6,86,47;XY;+8 [19], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,6.1,52.6,187,18250,15847,15846,7+3,MUD,CR 2
255421,2918,61,Yes,*,F,NHC,M1,47,77,80.5,79,47;XX+8 [20],GPR128(-)TFG(-) (In Frame);STIM1(+)NSD1(-) (out of frame);NUP98(+)NSD1(+) (In Frame),dup3q12.2; t(11;5)(p15.5;q35); t(11;5)(p15.5;q35),Intermediate Risk Cytogenetic Abnormality,Intermediate,NUP98 translocation,Poor, ,6,7.4,182,18134,18082,18081,7+3+dauno,MUD,CR 1
273919,3000,25,Yes, ,M,W,M2,25,56,98.8,71,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,67.7,67.7,N/A,11420,15839,15838,7+3,MUD,CR 1
274429,2821, ,Yes,*,M,W,M1,64,60,1.2,5,47;XY;+8 [10]/46;XY [10], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,27.4,27.4,N/A,9615,14660,14659,7+3,sib Allo,CR 1
275382,2822, ,Yes,*,M,W,M0,65,99,2.9,34,47;XY;+8 [20], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,32.3,32.3,N/A,6328,15150,15151,7+3,sib Allo; sib Allo,CR 1; xxxxx
290344,2916, ,Yes, ,F,W,M4,49,51,12.4,5,47;XX+11 [20], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,45.3,45.3,N/A,18137,15974,15975,7+3+3,sib Allo,CR 1
294154,2824, ,Yes,*,M,W,M5,44,74,8.8,5,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,0.3,0.3,N/A,9851,15047,15048,7+3+3,0,0
296361,2825,62,Yes,*,F,W,M5,31,83,137.2,6,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,6.4,7.5,196,11425,15096,15097,7+3+3,Auto,CR 1
303642,2919, ,Yes, ,F,NH/C,M1,54,72,13.1,90,46; XX[19], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,26.8,26.8,N/A,18138,18084,18083,7+3,0,0
311636,2826, ,Yes,*,F,W,M4,64,72,131.5,90,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,12.1,24.1,369,6329,15144,15145,7+3,0,0
312340,2827,64,No Sample,*,M,W,M2,33,33,2.8,0,46;XY[18]/46;XY;del(9)(q21q33)[1]/46;XY;del(20)(q?12)[1], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,5.7,8.8,172,6330,14119,14140,7+3+3+PSC,Auto; MUD,CR 1; Rel 1
322110,2877, ,Yes, ,F,W,M1,60,86,11.5,43,46;XX;9qh+[20],GPR128(-)TFG(-) (In Frame),dup3q12.2,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,41.4,41.4,N/A,18141,18222,18221,7+3,sib Allo,CR 1
327733,2992,8,Yes,*,F,W,M1,32,94,5.1,70,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,11.9,56.3,363,7494,14125,14115,7+3,MUD; MUD,CR2; CR>4
329614,2879,67,Yes, ,F,NH/C,M1,68,90,59.9,91,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,4.3,31.9,130,18144,18225,18290,7+3,0,0
332131,2880,68,Yes,*,M,NH/C,M1,24,77,223.8,76,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,9.8,20.5,298,18145,18227,18226,7+3+3,sib Allo,CR 2
335640,2974,26,Sample Failed,*,F,W,M5,67,85,45.3,3,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate,3:140959414-3:140959497(DEL),2.5,2.5,N/A,18298,16158,15953,Revlimid,0,0
346190,2830, ,Yes,*,F,W,M4,64,85,2.9,22,47;XX;i(11)(q10)[18]/46;XX [2], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,8.1,8.1,N/A,9690,15067,15068,Decitabine,0,0
348685,2921,70,Yes,*,F,NH/C,M4,55,69,27.6,57,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,6.3,8.1,192,18130,18682,18745,7+3+study drug,sib Allo,CR 1
369065,2831, ,No Sample,*,M,W,M0,59,61,1.4,2,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,17.2,20.2,522,7508,14493,14492,7+3+3,Auto,CR 1
375182,2925,71,Yes,*,M,W,M5,57,52,99.2,4,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,7.8,7.9,236,18251,16014,16015,7+3,0,0
380949,2832,72,Yes,*,F,W,M5,59,95,12.1,0,45;X;-X[21]/46;XX[9],MLLT10(-)PPP2R1B(-) (In Frame);MLLT10(-)MLL(-) (In Frame);C11orf1(-)KIAA0999(-) (In Frame);PPP2R1B(-)KIAA0999(+) (Out of Frame),t(10;11)(p12;q23.2); t(10;11)(p12;q23); inv11q23.1; inv11q23.2,Intermediate Risk Cytogenetic Abnormality,Intermediate,MLL translocation; poor risk,Poor, ,11.4,11.8,346,9853,15063,15064,7+3+3,0,0
387919,2926, ,Sample Failed,*,F,W,M1,57,91,19.8,91,47;XX;+8 [20], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,13.3,15.1,405,18652,16229,15981,7+3,Auto,CR 1
399253,2833, ,Yes,*,M,W,M4,77,80,40.4,2,46; XY[18], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,9.3,15.8,283,6332,18339,18338,7+3,0,0
400220,2970,27,Yes,*,F,W,M4,34,71,19.6,58,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,8.3,10.7,252,17910,16012,16040,7+3; IT,MUD,Refr dz
405655,2922, ,Sample Failed,*,M,W,M0,83,75,77.9,74,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,0.1,0.1,N/A,18147,18088,18087,no treatment,0,0
412761,2835, ,Yes, ,M,W,M5,48,83,116.2,3,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,77.3,77.3,N/A,9839,15074,15075,7+3+3,0,0
418499,2836, ,Yes,*,M,W,M4,35,90,52.9,18,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Poor, ,17,17,516,9688,15065,15066,7+3,0,0
426980,3002,28,Yes,*,M,W,M2,68,64,5.5,48,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,26.2,46.8,795,9693,15076,15077,7+3+Genasense,0,0
427366,2837, ,Yes,*,F,W,M5,66,90,111.8,7,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,0.7,0.7,N/A,9835,15166,15167,7+3,0,0
431799,2884, ,Yes,*,F,W,M1,44,86,13.5,17,46; XX[19], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,13.8,24.8,418,18302,18289,18232,7+3+3,Auto; MUD,CR 1; Rel 2
433325,2839,75,Yes,*,F,W,M2,51,64,42.1,79,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,10.2,16.3,310,7501,14133,14136,7+3+3,sib Allo,refr post relapse 1
440422,2907,29,No Sample,*,M,W,M0,69,82,1.6,0,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate,1:166453112-3:53150925(CTX);12:128688979-12:128689118(DEL);14:84366862-14:84371916(DEL);15:32718038-15:32718374(DEL);15:66836622-15:66836965(DEL);15:70173020-15:70175225(DEL);19:21508936-19:21509184(DEL);21:10155090-21:10156148(DEL);3:61450089-3:61450426(DEL);4:181278197-4:181280919(DEL);7:40845599-7:40846995(INV);9:88345663-9:88345767(INV),23.3,25.5,708,no RNA,17581,17580,Revlimid,MUD,refr dz
445045,2996,30,Yes, ,M,W,M2,75,63,2.5,2,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,73,73,N/A,11413,15819,15818,Decitabine,0,0
452198,2969,31,Yes, ,M,W,M5,55,97,72.6,8,46; XY[15], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,16.6,62.3,505,18294,17640,17639,7+3,sib Allo,CR 2
456892,2967,32,Yes, ,M,W,M4,58,58,19.9,10,46; XY[18], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,56.5,56.5,N/A,17998,16031,16032,7+3+3,Auto,CR 1
470690,2933,77,Yes,*,M,W,M4,58,79,101.3,64,46;XY;i(17)(q10)[15]/47;XY;idem+13[3]/46;XY[2], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,4.6,4.6,N/A,18156,15976,15977,7+3+3,0,0
499862,2923, ,Sample Failed,*,M,W,M4,78,70,16.8,28,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,0.6,0.6,N/A,18149,18090,18089,Revlimid,0,0
507202,2924, ,Yes, ,M,NH/C,M4,59,75,29.7,17,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,26,26,N/A,18131,18092,18091,7+3+study drug,sib Allo,CR 1
509754,3011,7,Yes, ,F,W,M1,21,91,8.2,83,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,81.9,81.9,N/A,9681,14668,14667,7+3+3,sib Allo,refr dz post induction
530962,2938, ,Yes,*,M,W,M7,76,33,3.6,6,45;X;-Y[3]/46;XY [17],TNK1(-)ZBTB7A(-) (Out of Frame);POLR2A(-)FBN3(-) (Out of Frame);NVL(-)FMN2(+) (Out of Frame),t(17;19)(p13.1;p13.3); t(17;19)(p13.1;p13); dup1q41-q43,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,7.2,9.9,220,11419,15855,15813,Decitabine,0,0
545259,2979,33,Yes, ,F,W,M1,30,86,22.9,88,46; XX[20],LRBA(+)SH3D19(+) (In Frame),dup4q31.3,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,47,47,N/A,17887,15807,15808,7+3+3,Auto,CR 1
548327,2990,34,Yes, ,M,W,M1,51,85,63.7,85,46; XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,34.1,42.1,1036,17888,17431,17432,7+3+3,Auto; sib Allo,CR 1; xxxxx
553863,2890, ,Yes,*,M,NH/C,M0,69,60,6.1,22,47;XY;+9[10]/46;XY[10], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,0.5,0.5,N/A,18161,18245,18244,Revlimid,0,0
558395,2842, ,Yes,*,M,W,M4,64,95,2.3,0,46;XY;del(11)(p12)[2]/46;XY[18],MLLT10(+)MLL(+) (In Frame),t(10;11)(p12;q23),Intermediate Risk Cytogenetic Abnormality,Intermediate,MLL translocation; poor risk,Poor, ,0.3,0.3,N/A,7505,14146,14150,no treatment,0,0
569053,2843,82,Yes,*,M,W,M6,77,75,2.6,8,46;XY;del(20)(q11.2)[23]/92;XXYY;del(20)(q11.2)x2[2]/46;XY[3], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,3.7,6.3,111,9845,18333,18332,7+3,0,0
573988,2973,35,Yes,*,F,W,M4,67,75,15.2,10,46; XX[16], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,12,20.5,365,18349,16230,15973,7+3,0,0
578179,2927, ,Yes,*,F,NH/C,M1,88,33,2.9,0,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,2.4,2.4,N/A,18151,18684,18683,Revlimid,0,0
593890,2940, ,Yes,*,M,W,M2,35,34,33.5,40,47;XY;+21 [6]/46;XY[13], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,14.6,55.4,445,11418,15817,15816,7+3+3,MUD; MUD,CR 2; CR 4
606061,2845,84,Yes,*,F,W,M2,37,52,18.7,33,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,8.5,9.3,259,6334,15148,15149,7+3+3,Auto,CR 1
617776,2930, ,Yes,*,F,NH/C,M2,62,72,27.7,49,46; XX[20],NUP98(-)NSD1(-) (In Frame),t(11;5)(p15.5;q35),Normal Karyotype,Intermediate,NUP98 Translocation,Poor, ,4.8,7.1,147,18052,18098,18097,7+3+AMD,MUD,res dz post rel 1
632729,2931, ,Yes,*,M,W,M2,75,76,98.2,80,46;XY;9qh+[19],BIRC6(+)LTBP1(+) (In Frame),dup2p22.3,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,0.1,0.1,N/A,18193,18100,18099,no treatment,0,0
635258,2932, ,Yes, ,M,W,M5,62,85,59.3,22,46; XY[20],MLL3(+)ACTR3B(-) (Out of Frame),dup7q36.1,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,42.1,42.1,N/A,18194,18102,18101,7+3,0,0
670224,2848, ,Yes,*,M,W,M4,62,65,118.8,65,46; XY[20],NCOR2(-)SCARB1(-) (Out of Frame),dup12q24.1-31,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,13.4,14.5,406,9683,15055,15056,7+3+Genasense,sib Allo,CR 1
700717,2983,36,Yes,*,M,W,M0,45,75,2.3,0,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,3.8,11.2,116,17999,17565,17564,7+3,MUD,Rel 1
702808,2987,37,Yes,*,F,W,M5,75,41,7.3,0,46;XX[18], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,5.3,6.3,161,18000,17661,17660,Revlimid,0,0
723101,2934,89,Yes,*,M,NH/C,M1,65,79,67.9,84,46;XY[15], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,2.7,6.6,82,18053,18121,18120,7+3,MUD,refr dz
730817,2851, ,Yes,*,F,W,M5,66,32,78.5,11,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,5.9,7.7,180,9840,15080,15081,Decitabine,0,0
737451,2896,91,Yes,*,F,W,M5,21,90,93,72,46;XX[15], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,7.5,7.5,N/A,18199,18321,18320,7+3,MUD,Refr dz
753374,2989,38,Sample Failed,*,M,W,M2,29,45,2.2,9,46;XY;15pstk+[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,8.9,11.9,270,18001,17437,17438,7+3+3,Auto; sib Allo,CR 1; Refr post Rel 1
766126,2936, ,Yes,*,F,NH/C,M0,60,50,2.1,14,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,13.8,13.8,N/A,18054,18168,18167,LBH/Decitabine,MUD,refr dz
775109,3005,39,Yes, ,M,W,M5,45,81,1.6,0,46;XY[20],MLLT10(+)MLL(+) (In Frame),t(10;11)(p12;q23),Normal Karyotype,Intermediate,MLL translocation; poor risk,Poor,5:168977114-5:168977145(DEL);5:585454-5:585654(DEL);6:150735535-6:150735635(DEL);9:36352882-9:36354094(DEL),100.5,100.5,N/A,9844,15428,15083,7+3+3,Auto,CR 1
804168,2976,40,Yes,*,M,W,M1,53,86,88.1,52,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,7.7,30,235,17889,16159,15955,7+3+3,sib Allo,CR 2
807615,2853, ,Yes,*,M,W,M1,51,85,103.6,85,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,3.1,3.1,N/A,6336,14686,14685,7+3+3+PSC,0,0
807970,2984,2,Yes, ,M,W,M1,38,86,39.8,97,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,71.3,71.3,N/A,11416,14503,14502,7+3,0,0
808642,3006,6,Yes,*,M,W,M1,61,49,2.9,14,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,12,15.5,365,11423,17634,17633,Decitabine,0,0
816067,2981,41,Yes, ,F,W,M5,35,87,72.1,8,46; XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,44.4,44.4,N/A,18002,15805,15806,7+3; IT,MUD,CR 1
817156,2975,42,Yes,*,M,B,M2,54,67,45,83,46;XY[19],BCL11A(-)GRIP2(-)* (Out of Frame),t(2;3)(p16.1; p24-p23),Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,8.5,34,257,18003,15956,15957,Cytarabine only,MUD,CR 3
826984,2854, ,Yes,*,F,W,M4,51,73,2.9,2,45;Xc;t(5;21)(q31;q22)[18]/45;idem;t(1;6)(?q21;p23)[1]/45;Xc[1],RUNX1(-)ADAMTS19(+) (Out of Frame);RUNX1(+)PRRC1(+) (Out of Frame),t(21;5)(q22.3;q23.3); t(21;5)(q22.3;q23.2),Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,8,11.1,244,6337,15158,15159,7+3+3,Auto,CR 1
831711,2964,4,Yes, ,F,W,M1,57,64,2.5,61,46; XX[19], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,59.5,59.5,N/A,13066,17638,17637,7+3,0,0
849660,3008,5,Yes,*,M,W,M1,22,71,1.2,90,46;XY[30], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,7.7,27,235,10567,14505,14504,7+3+3,MUD; MUD,CR1; CR3
851929,2898, ,Yes, ,F,NH/C,M1,69,42,10.1,32,47;XX+8 [20], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,36.1,36.1,N/A,18205,18325,18324,Revlmd then Decitbne;7+3;5+2,sib Allo,CR 1
868231,2856,96,Yes,*,M,W,M4,63,82,76.7,39,46;XY[20],NUP98(-)NSD1(-) (In Frame),t(11;5)(p15.5;q35),Normal Karyotype,Intermediate,NUP98 Translocation,Poor, ,5.3,5.3,N/A,11412,15134,15135,7+3+Genasense,0,0
868442,2947, ,Sample Failed, ,M,NH/C,M4,52,75,298.4,51,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,25.9,25.9,N/A,18058,18180,18179,7+3+study drug,0,0
869586,3009,43,Yes,*,M,W,M4,23,51,27.1,63,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,7.7,19,235,10571,15100,15101,7+3+3,Auto; sib Allo,CR 1; CR 2
869922,2955,101,Yes,*,F,W,M2,56,60,202.7,96,46;XX[20],UBR4(+)ZFP37(+) (Out of Frame),t(1;9)(p36.13;q32),Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,9.6,16.4,291,18352,15983,15982,7+3+3,Auto; MUD,CR 1; CR 2
906708,2971,44,Yes,*,F,W,M4,76,91,5,16,46;XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,17,25.8,518,18005,17439,17440,7+3,0,0
907786,2985,45,Yes,*,F,W,M5,81,53,12.3,7,46;XX[20],MLLT10(+)CEP164(-) (Out of Frame);MLLT10(+)MLL(+) (In Frame),t(10;11)(p12;q23.3); t(10;11)(p12;q23),Normal Karyotype,Intermediate,MLL translocation; poor risk,Poor, ,9.2,9.2,N/A,18006,17441,17442,Revlimid,0,0
914247,2948,98,Yes,*,M,W,M4,67,30,26.1,6,46;XY[13], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,18.1,18.1,N/A,18207,18182,18181,Revlimid,0,0
923966,2956,102,Yes,*,M,W,M5,61,89,8.4,0,46;XY;t(9;11)(p22;q23)[7]/47;XY;t(9;11)(p22;q23)[7]/46;XY[4],MLL(-)MLLT3(-) (In Frame);VTI1B(-)RDH11(-) (Out of Frame),t(11;9)(q23;p22); dup14q24.1,MLL translocation; t(9;11),Intermediate,MLL translocation; t(9;11),Intermediate, ,3.2,5.7,97,18257,16016,16017,CLAM,0,0
933124,2993,1,Yes,*,F,W,M1,57,100,102.5,91,46;XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate,2:88210954-2:88211270(DEL);20:61859659-20:61859782(DEL);3:8697749-3:8697853(DEL),11.1,24.6,338,7502,13787,13786,7+3+3,Auto; sib Allo,CR 1; Rel 1
936028,2859, ,Yes,*,M,B,M2,40,47,8.3,23,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,8,10.2,244,10568,15078,15079,7+3+3,0,0
962561,2899, ,Yes,*,F,W,M4,76,37,2.7,0,46;XX+13;21[cp17]/46;XX[3], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,17.3,22.3,527,11424,15851,15850,Decitabine,0,0
964886,2862, ,Yes, ,F,B,M3,33,100,0.9,0,46;XX[20],PML(-)RARA(-) (In Frame),t(15;17)(q22;q21),Normal Karyotype,Intermediate,PML-RARA,Good, ,69,69,N/A,9691,14507,14506,7+3+ATRA,0,0
972783,2959, ,Yes,*,M,W,M0,71,90,1,13,47;XY;+13[5]/46;XY[15], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,13.4,15.4,408,18816,16157,15951,Revlimid,0,0
975684,2864, ,No Sample,*,F,W,M1,53,82,1.2,42,47;XX;+8[19]/46;XX[2], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,20.1,20.1,N/A,9692,15431,14510,7+3+3,Auto,CR 1
982009,2900, ,Yes,*,M,Unk/B,M1,70,84,48,49,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,4.9,6.3,148,18209,18327,18326,CLAM,0,0
984036,2865, ,Yes,*,M,W,M1,75,40,6.4,48,47;XY;+21[11]/48;XY;+3;+21[8], , ,Intermediate Risk Cytogenetic Abnormality,Intermediate,Intermediate Risk Cytogenetic Abnormality,Intermediate, ,2.3,2.3,N/A,9695,14672,14671,Decitabine,0,0
989176,2903, ,Yes,*,F,W,M1,76,99,297.4,98,46;XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,0.4,0.4,N/A,13067,14682,14681,7+3,0,0
991612,2995,46,Yes, ,M,W,M2,63,35,0.6,0,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate,20:23051193-20:23051633(DEL),69.7,73.6,2119,11421,15848,15849,7+3,sib Allo,CR 1
992966,2866,100,Yes,*,M,W,M1,67,89,30.8,61,46;XY[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,4.5,5.5,137,9686,14670,14669,7+3,0,0
997292,2867, ,Yes,*,F,W,M2,66,70,3.4,6,46;XX[20], , ,Normal Karyotype,Intermediate,Normal Karyotype,Intermediate, ,5.2,5.2,N/A,18212,15142,15143,7+3,0,0
295,2810, ,Yes,*,F,B,M2,76,48,61.6,88,ND, , ,N.D.,N.D.,N.D.,N.D., ,1.3,1.3,N/A,9833,15084,15085,no treatment,0,0
327929,2829, ,No Sample,*,M,B,M6,50,70,5.5,0,N.D.; -5q by FISH, , ,N.D.,N.D.,N.D.,Poor, ,3.7,8.9,112,9862,15051,15052,7+3+3,0,0
721214,2895,88,Yes,*,F,NH/C,M1,41,92,134.4,90,N.D., , ,N.D.,N.D.,N.D.,N.D., ,5.7,5.7,N/A,18197,18319,18318,7+3,0,0
724606,2850,90,No Sample,*,F,B,M2,72,45,3,0,Incomplete-46;XX[2], , ,N.D.,N.D.,N.D.,N.D., ,1.9,1.9,N/A,7496,14121,14128,7+3,0,0
866660,2946, ,Yes, ,M,NH/C,M2,41,47,43.1,62,incomplete-46;XY;del(12)(p11.20[2]/46;XY[3], , ,N.D.,N.D.,N.D.,N.D., ,20.8,24.4,632 neck mass,18057,18688,18746,7+3+3; then 5+2+2,MUD,CR 1
100232,2908, ,Yes,*,M,W,M2,81,46,1.5,0,46~49;XY;del(3)(p14);del(5)(p11.2q33);del(17)(q21q21);add(21)(p11.2);+22;mar[cp20],IFNGR2(-)GART(-) (Out of Frame),inv21q22.11,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,1.4,1.4,N/A,18059,18074,18073,Revlimid,0,0
123804,2910, ,Yes,*,F,W,M5,61,71,34.6,55,47;XX;+der(5)t(2;5)(p11.2;q11.2)?;t(8;16)(p11.2;p13.3)[19],CREBBP(+)KAT6A(+)(2) (In Frame),t(16;8)(p13.3;p11),Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,0,0,N/A,18061,18078,18077,no treatment,0,0
128392,2904, ,Yes,*,M,W,M0,65,83,0.9,0,46~50;XY;-1;del(2);del(5)(q22q33);der(7)t(1;7)(q21;p13);add(7)(p11.1);+8;+add(11);del(12)(p12);del(13)(q22); 15;add(17)(p11.1);-20;+22 {cp20}Complex Cytogenetics ; including 5q-;+8;,MDM4(+)DNMT3B(+) (Out of Frame),t(1;20)(q32;q11.2),Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,17.1,17.1,N/A,18295,15800,15799,7+3,sib Allo,CR 1
147796,2813, ,Yes,*,M,W,M4,78,40,9.9,6,44-45;X;-Y;-5;add(16)(q22);-17;-18;iso(21);+mars[cp5]/82-84;XX;-Y;-3;-4;-11;-12;-19;-21;+21[cp5}, , ,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,1.3,1.3,N/A,10570,15098,15099,Azacitidine,0,0
150951,2814, ,Yes,*,F,W,M0,39,75,2.3,4,46;XX;del(5)(q22q33)[4]/46;XX[16],GAS6(-)FAM70B(+) (Out of Frame),dup13q34,Poor Risk Cytogenetic Abnormality,Poor,Poor Risk Cytogenetic Abnormality,Poor, ,22.2,26.3,675,6324,14130,14134,7+3+3,Auto; MUD,CR 1; CR 2
193139,2915, ,Yes,*,F,NH/C,M2,73,32,15.1,11,46;XX;del(3)(q23q26.2);der(7)t(1:7)(q32;q32);del(10)(q22q25);t(13;16)(q34;p11.2)dup(21)(q22)[cp20],GRID1(+)DPM1(+) (In Frame);RUNX1(+)MECOM(+)  (In Frame),t(10;20)(q22;q13.13); t(21;3)(q22.3;q26),Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,0.5,0.5,N/A,18064,18080,18079,Decitabine,0,0
195182,2817,57,Yes,*,M,W,M2,63,57,77.3,70,45;XY;-7; t(9;22)(q34;q11.20) [19]/46;XY[1],BCR(-)ABL1(-) (In Frame),t(22;9)(q11.23;q34.1),BCR-ABL1,Poor,BCR-ABL1,Poor, ,9.3,9.3,N/A,9694,15071,15072,7+3,sib Allo,refr dz
237983,2874, ,Yes, ,M,NH/C,M2,59,70,11.5,48,45;XY;-7[20], , ,Poor Risk Cytogenetic Abnormality,Poor,Poor Risk Cytogenetic Abnormality,Poor, ,35.2,35.2,N/A,18065,18218,18217,7+3+3,MUD,CR 1
242129,2911,59,Yes, ,F,B,M4,51,39,50.3,39,44~46;XX;del(11)(q23);der(19)?t(11;19)(q23;p13.1)[cp11]/44~45;XX;-19[cp4]/46;XX [5],MLL(-)ELL(-) (In Frame),t(11;19)(q23;p13.1),MLL translocation; poor risk,Poor,MLL translocation; poor risk,Poor, ,3.7,61.2,112,18066,16010,16011,7+3,MUD,CR 2
269542,2820, ,Yes,*,M,B,M0,76,74,14.5,82,53~56;XY;+1;del(2)(q33q34);+8;+10;+11x2;+13x1-2;+14;del(17)(p11.2);+19;add(21)(q22);+22[cp20],GOSR1(-)ZNF207(-) (In Frame),del17q11.2,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,0.3,0.3,N/A,9843,15092,15093,7+3,0,0
303818,2917,63,Yes,*,F,W,M0,41,42,47.6,74,46;XX;i(17)(q10)[1]/45;sl-7[2]/48;sl;+13;+19[3]/46;XX[15], , ,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,39,57.3,1187,18139,16008,16009,7+3,MUD,refr dz
319955,2876, ,Yes, ,F,W,M2,45,56,29.4,37,46;XX;1~50dmin[12]/46;idem;der(6)t(6;?)(q22;?)[2]/46;XX[6],CR593328(-)FAM49B(+) (Out of Frame);PVT1(+)ASAP1(+)(2) (Out of Frame),inv8q24.21; inv8q24.1-q24.2,Poor Risk Cytogenetic Abnormality,Poor,Poor Risk Cytogenetic Abnormality,Poor, ,59,59,N/A,18140,18331,18330,7+3,MUD,CR 1
325028,2920,65,Yes,*,M,W,M2,44,39,34.8,83,45~46;XY;add(X)(q22)[7];Y[4];der(5)t(5;17)(q13;21)[18];-7[18];+8[17];del(12)(q23)[16];-17[18];add(18)(p11.2)[14][cp18],C12orf59(-)XIAP(+) (Out of Frame);CHST11(-)ATP1B4(-) (In Frame);KPNB1(-)ACE(-) (In Frame);KSR1(-)ODZ1(-) (In Frame);OLR1(-)XIAP(-) (In Frame);PTPN2(+)UBLCP1(+) (Out of Frame);WSB1(+)NBR1(+) (Out of Frame),t(12;X)(p13.2;q25); t(12;X)(q?;q24); del17q21.3-23.3; t(17;X)(q11.1-q11.2;q25); t(12;X)(p13.2-p12.3;q25); t(18;5)(p11.3-p11.2;q33.3); del17q11.1-q21.31,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,5.2,11.8,157,18142,16227,15959,7+3+3,sib Allo,CR 1
326772,2878,66,Yes,*,F,W,M2,47,37,12,0,39~47;XX;del(5)(q13q33);-7;der(8)t(8;?8;8)(p23;?p11.2p23;q11.2);der(14)t(1;14)(p12;p11.2)der(1)t(7;16)(p15;q22);+2mar[cp19], , ,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,12.2,12.2,N/A,18143,18224,18223,7+3,Haplo,Refr dz
400830,2882, ,Yes,*,F,W,M2,73,37,1.7,16,45;XX;-7[12]/46;XX[8], , ,Poor Risk Cytogenetic Abnormality,Poor,Poor Risk Cytogenetic Abnormality,Poor, ,11,11,N/A,18146,18231,18230,Decitabine,0,0
407992,2834,73,Yes,*,M,W,M4,33,71,25.9,14,46;XY;t(11;19)(q23;p13)[17]/46;XY;t(11;19)(q23;p13);inv(12)(p12p13)[3],MLL(-)ELL(-) (In Frame),t(11;19)(q23;p13.1),MLL translocation; poor risk,Poor,MLL translocation; poor risk,Poor, ,7.7,7.7,N/A,7504,14144,14149,7+3+3,0,0
410324,2883, ,Yes, ,M,W,M5,60,94,6.7,30,52~54;XY;+2;+4;+6;+8;del(11)(q23);+19;+19;+21[17]/46;XY[3],MLL(+)MLLT4(+) (In Frame),t(11;6)(q23;q27),MLL translocation; poor risk,Poor,MLL translocation; poor risk,Poor, ,47.2,47.2,N/A,18154,15802,15801,7+3,sib Allo,CR 1
415172,2929, ,Yes,*,F,W,M0,71,55,5.6,50,41~44;X;?i(X)(p10);-7;der(12)t(8;12)(q11.2;p11.2);-8 [cp11]/46;XX[8[, , ,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,4.6,4.6,N/A,no RNA,16228,15971,Decitabine,0,0
432398,2838,74,Yes,*,M,W,M2,67,50,2.1,17,46;XY;del(5)(q11.2q31);-7;+8;+11;add(11)(q23);der(16;17)(q10;q10)[18]/51;idem;+1;+5;+8;+10;+21 [2],AF086125(+)USP22(+) (Out of Frame);CA7(-)USP22(+) (Out of Frame),t(16;17)(q22;p11.2); t(16;17)(q22.1;p11.2),Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,10.3,12.4,313,9834,14675,14676,7+3,0,0
434640,2885,76,Yes,*,M,NH/C,M0,71,97,5.4,54,43;XY-3;del(5)(q12q33);-7;der(10)t(10;11)(q26;q13);-12;-18;+2mar[20],KSR2(-)SETMAR(+) (Out of Frame),t(12;3)(q24.22-23;p26.1),Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,4.8,7,146,18155,18235,18234,Decitabine then 7+3,0,0
498463,2887,79,Yes,*,F,NH/C,M1,60,87,46.5,65,46;XX;del(7)(q11.2)[20], , ,Poor Risk Cytogenetic Abnormality,Poor,Poor Risk Cytogenetic Abnormality,Poor, ,4.9,17.4,150,18157,18239,18238,7+3,sib Allo,CR 1
570755,2844, ,Yes,*,M,W,M2,63,80,17,71,46;XY;t(11;19)(q23;p13)[20],MLL(-)ELL(-) (In Frame),t(11;19)(q23;p13.1),MLL translocation; poor risk,Poor,MLL translocation; poor risk,Poor, ,3.9,3.9,N/A,9689,15059,15060,Decitabine,0,0
594368,2891, ,Yes,*,M,NH/B,M1,42,68,10.7,51,45;XY;der(7)(t:7;12)(p11.1;p11.2);-12;-13;+mar[19]/46;XY[1], , ,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,14.9,21.5,453,18162,18335,18334,7+3+3,Auto; MUD,CR 1; pers dz p/Rel 2
605322,2928,83,Yes,*,F,NH/AA,M1,43,87,171.9,91,45;XX;-7[20], , ,Poor Risk Cytogenetic Abnormality,Poor,Poor Risk Cytogenetic Abnormality,Poor, ,4,4,N/A,18132,18096,18095,7+3+AMD,0,0
633734,2847, ,Yes,*,M,W,M1,53,72,2.7,41,46;XY;del(7)(q21q36)[18]/46;XY[2], , ,Poor Risk Cytogenetic Abnormality,Poor,Poor Risk Cytogenetic Abnormality,Poor, ,19.3,52.7,588,9680,18354,18353,7+3+3,MUD,CR 1
690397,2893, ,Yes,*,M,W,M5,45,95,5.1,6,46;XY;t(6;11)(q27;q23)[15],MLL(-)MLLT4(-)(2) (In Frame),t(11;6)(q23;q27),MLL translocation; poor risk,Poor,MLL translocation; poor risk,Poor, ,6.6,6.6,N/A,18195,18315,18314,7+3,sib Allo,CR 1
692900,2849, ,Yes, ,M,W,M0,39,83,5,53,47;XY;del(5)(q22q33);t(10;11)(p13~p15;q22~23);i(17)(q10)[3]/46;XY[17],MLLT10(+)PICALM(+) (2 (In Frame)),t(10;11)(p12;q14),Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,95.5,95.5,N/A,7506,14147,14151,7+3+3,MUD,CR 1
708512,2945,87,Sample Failed,*,F,W,M4,65,90,48.5,76,46~47;XX;+i(4)(q10)[12];-8[5];10[3][cp20], , ,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,1.9,7.8,57,18255,15845,15844,7+3,sib Allo,CR 2
717456,2894, ,Yes,*,F,W,M5,50,81,6.7,10,45;XX;-7;t(9;11)(p22;q23)[19]/46;XX[1],MLL(-)MLLT3(-) (In Frame),t(11;9)(q23;p22),MLL translocation; t(9;11),Poor,MLL translocation; t(9;11),Intermediate, ,5.6,5.6,N/A,18196,18317,18316,7+3+3,Auto,CR 1
729805,2935, ,Yes,*,M,W,M4,66,81,2.2,12,44~47;XY;del(5)(q22q35)[20];-7[14];-8[6];der(12)t(10;12)(p11.2q21)[2];add(14)(p12)[11];-17[13];der(17)t(10;17)(q11.2;p13)[14];-18[7];add(18)(p11.2)[7];-21[10];i(21)(q10)[4];-22[4];+mar[10];+mar1x2[6][cp20], , ,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,1.6,1.6,N/A,18198,18166,18165,7+3,0,0
740266,2949, ,Yes,*,M,W/Nat Amer,M0,58,59,47.2,72,47;XY;+22[10]/47;XY;+8[7]/45;XY;del(3)(p21);del(4)(p12p15);-7;?dup(7)(q11.2q36)[3], , ,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,32.6,32.6,N/A,18200,16024,16025,7+3+3,MUD,CR 1
767969,2939, ,Yes, ,M,W,M1,72,88,37.5,18,37~49;XY;+Y;der(1)add(1)(p13)del(1)(q21q25);-5;der(7)inv(7)(p15q11.2)?inv(7)(q22q32);+17;add(17)(p13);+21;+mar[cp20],MTOR(+)CHD1(+) (Out of Frame);CDC73(-)FAM172A(-) (Out of Frame);EDIL3(-)MKLN1(-) (Out of Frame),t(1;5)(p36.2;q15-q21); t(1;5)(q25;q15); t(5;7)(q14;q32),Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,36.9,36.9,N/A,18202,18170,18169,7+3,MUD,0
794178,2941, ,Yes,*,M,W,nc,73,90,58.9,0,46;XY;t(9;22)(q34;q11.2)[13]/34~37;idem;-3;del(4);-4;-5;-7;-9;-10;t?(11;12);-12;-14;-14;-16;-17;-22[cp6]/46;XY[1],BCR(+)ABL1(+)(2) (In Frame);DOCK6(-)CCDC130(-) (In Frame),t(22;9)(q11.23;q34.1);  inv19p13.2,BCR-ABL1,Poor,BCR-ABL1,Poor, ,0.2,0.2,N/A,18203,18172,18171,no treatment,0,0
806794,2943,92,Yes,*,F,NH/C,M1,70,32,0.7,6,46;XX;del(5)(q11.2q33)[1]/48~52;idem;+1;+?del(5)(q15q33);+11;+11;?t(12;22)(p13;q12);-13;-17;+i(22)(q10);+i(22)(q10);+mar[cp19],RSAD2(+)ELMOD3(-) (Out of Frame),inv2p25.2-p11.2,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,4.2,4.2,N/A,18055,18174,18173,Decitabine,0,0
809653,2952,93,Yes,*,F,W,M1,60,62,16,29,44~47;XX;t(1;15)(q32;q26)[14];del(5)(q13q33)[19];-7[20];+8[7];del(12)(p11.2p11.2)[15];del(17)(q21)[8];der(22)t(1;22)(p13;p11.2)[20];+mar[13][cp20],NF1(+)LRRC37B(+) (In Frame),del17q11.2,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,1.9,1.9,N/A,18204,16020,16021,7+3,0,0
852559,2855,94,Yes,*,M,W,M1,18,86,41.5,90,48;XY;+4;t(10;11)(p13;q21);del(12)(p11.2);+19[6]/48idem;-17;+i(17)(q10)[14],MLLT10(+)PICALM(+)(2) (In Frame);GAS6(+)FAM70B(-) (Out of Frame),t(10;11)(p12;q14); dup13q34,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,6.7,7.2,203,9847,14688,14687,7+3+3,MUD,refr dz
861663,2944,95,Yes,*,M,NH/C,M0,48,92,111,87,45;XX-7[5]-only 5 metaphases,RPN1(+)MECOM(+) (In Frame),del3q21.3-q26,Poor Risk Cytogenetic Abnormality,Poor,Poor Risk Cytogenetic Abnormality,Poor, ,2.4,2.4,N/A,18056,18686,18685,7+3+study drug,0,0
884262,2857,97,Yes,*,M,W,M6,54,30,2.3,0,42;XY;-5;-7;add(12)(p13);t(14;15)(q10;q10);der(17)t(5;17)(p13;p11.2);-18[6]/40;idem;-11;-add(12)(p13);der(12)t(?;12)(?;p13);-19[6]/41;idem;-der(17)[3]/41;idem;-der(17);+mar1;+mar[3]/41;idem;der(1)der(1)(p12)add(1)(p12);+der(1)(q21)add(1)(q21);-3;-8[2],H2AFX(-)WDR18(-) (In Frame);DDX20(-)TBX15(-) (In Frame);ZNF585B(-) C2CD2L(+) (In Frame),t(11;19)(q23.3;p13.3); inv1p21.1-p11.1; t(19;11)(q13.12;q23.3),Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,6.5,10,198,9838,15057,15058,7+3+3,MUD,CR 1
938150,2860, ,Yes,*,F,W,M7,60,58,0.8,0,44;XX;t(4;11)(q21;q23);-5;-7;add(12)(q24);add(18)(q23);del(20)(q12)[3]/43;XX;del(3)(p12);der(3)t(3;3)(p21;q2?7);psu dic(5;7)(q13;p22);-10;-15;-17;add(18)(p11.2);-21;+22;+mar[cp14]/46;XX[3],USP25(-)TRAPPC10(+) (Out of Frame),inv21q11.2-q22.3,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,12,13.6,366,9836,15090,15091,7+3,sib Allo,CR 1
957664,2861, ,Yes,*,M,W,M5,76,78,4,0,47;XY+8 [15]/48;XY+8+8[4]/46;XY[1], , ,Poor Risk Cytogenetic Abnormality,Poor,Poor Risk Cytogenetic Abnormality,Poor, ,0.6,0.6,N/A,9848,15069,15070,low dose Ara C,0,0
974749,2863, ,Yes,*,M,W,M1,63,81,46.4,97,48;XY;+8;+8[16]/46;XY[4], , ,Poor Risk Cytogenetic Abnormality,Poor,Poor Risk Cytogenetic Abnormality,Poor, ,1.2,1.2,N/A,6338,14509,14508,7+3,0,0
986000,2868, ,Yes,*,M,W,M7,77,47,1.9,0,46;XY;-5;+8;del(9)(q22);add(10)(q26);der(15;19)(q10;q10);add(17)(p11.2);-20;-21;add(21)(p11);add(22)(q13);+3mar[20],NEK1(-)CLCN3(+) (Out of Frame);ZNF483(-)GAPVD1(+) (Out of Frame);NR6A1(+)OBP2B(-) (Out of Frame),dup4q33; inv9q31.3-33.3; inv9q33.3-34,Complex Cytogenetics,Poor,Complex Cytogenetics,Poor, ,4.5,4.5,N/A,9841,15164,15165,no treatment,0,0
987523,2901,99,Yes,*,M,NH/B,M1,27,77,90.4,88,46;XY;t(9;22)(q34;q11.2[4]/50;idem;+8;+10;+21;+der(22)(t(9;22)(q34;q11.2)[16],BCR(-)ABL1(-)(2) (In Frame);SEC63(-)FIG4(-) (Out of Frame),t(22;9)(q11.23;q34.1); inv6q21,BCR-ABL1,Poor,BCR-ABL1,Poor, ,3,10.5,94,18210,18329,18328,7+3+3; gleevec,MUD,pers dz post rel 1